ArticleBMJ case reports2020
Erythema nodosum as a cutaneous manifestation of COVID-19 infection.
Article in BMJ case reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19 - A systematic review of the literature.Journal of autoimmunity · 2021Pooled it
- Dose-dependent erythema nodosum after initiation of semaglutide.JAAD case reports · 2024Article
- COVID-19-Associated Erythema Nodosum Detected on FDG PET/CT.Diagnostics (Basel, Switzerland) · 2023Article
- Erythema Nodosum in Children: A Narrative Review and a Practical Approach.Children (Basel, Switzerland) · 2022Review
- Atypical Presentation of Erythema Nodosum Following Pfizer-BioNTech COVID-19 Vaccine.Medical archives (Sarajevo, Bosnia and Herzegovina) · 2022Article
- SARS-CoV-2 Infection and Vaccination Cutaneous Manifestations for the Inpatient Dermatologist.Current dermatology reports · 2022Review
- Erythema nodosum, zoster duplex and pityriasis rosea as possible cutaneous adverse effects of Oxford-AstraZeneca COVID-19 vaccine: report of three cases from India.Journal of the European Academy of Dermatology and Venereology : JEADV · 2022Article
- Erythema nodosum-like eruption in coronavirus disease 2019: A case report and literature review of Asian countries.The Journal of dermatology · 2021Review
- Atypical erythema nodosum triggered by COVID-19 infection.JAAD case reports · 2021Article
- Systemic and organ-specific immune-related manifestations of COVID-19.Nature reviews. Rheumatology · 2021Review
- Time of Onset of Selected Skin Lesions Associated with COVID-19: A Systematic Review.Dermatology and therapy · 2021Review
- A systematic review of dermatologic manifestations among adult patients with COVID-19 diagnosis.Skin health and disease · 2021Article
- Synthesis of the Data on COVID-19 Skin Manifestations: Underlying Mechanisms and Potential Outcomes.Clinical, cosmetic and investigational dermatology · 2021Review
- Review
- Dermatological Manifestations Associated with COVID-19 Infection.Indian journal of dermatologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Erythema nodosum (EN) is a common dermatological manifestation with many different aetiologies. Often however, the aetiology remains unidentified. We present here a 42-year-old male patient with an EN that is due to an acute COVID-19 infection. Most of the usual aetiologies were excluded by laboratory testing and imaging studies. This case is, to our knowledge, the first report of this cutaneous manifestation in the context of a COVID-19 infection. The EN was successfully treated with the disappearance of the COVID-19 infection and topical corticosteroids.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.